Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds
Authors
Keywords
-
Journal
OncoImmunology
Volume 9, Issue 1, Pages 1710052
Publisher
Informa UK Limited
Online
2020-01-13
DOI
10.1080/2162402x.2019.1710052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
- (2018) G N Hortobagyi et al. ANNALS OF ONCOLOGY
- Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) – A systematic review and meta-analysis
- (2018) Alona Zer et al. CANCER TREATMENT REVIEWS
- The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
- (2018) Beatriz de la Torre et al. MOLECULES
- End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma
- (2017) Antje Hoering et al. Future Oncology
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
- (2017) Georgina V Long et al. LANCET ONCOLOGY
- Dosing Three‐Drug Combinations That Include Targeted Anti‐Cancer Agents: Analysis of 37,763 Patients
- (2017) Mina Nikanjam et al. ONCOLOGIST
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns
- (2017) Mina Nikanjam et al. OncoImmunology
- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Surrogate end points for overall survival in breast cancer trials: A review
- (2016) Frédéric Fiteni et al. BREAST
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
- (2016) Stéphane Champiat et al. CLINICAL CANCER RESEARCH
- Unknown
- (2016) INTERNATIONAL JOURNAL OF CANCER
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers
- (2016) Sariah Liu et al. Oncotarget
- Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer
- (2016) John L. Silberstein et al. Current Urology Reports
- Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies
- (2015) Diego Tosi et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
- (2015) Maria Schwaederle et al. JOURNAL OF CLINICAL ONCOLOGY
- Unknown
- (2015) STATISTICS IN MEDICINE
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2014) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs
- (2013) D. L. Jardim et al. CLINICAL CANCER RESEARCH
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
- (2013) B. Zhao et al. Cancer Discovery
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Progression-Free Survival
- (2010) David Lebwohl et al. CANCER JOURNAL
- Immunotherapy for Advanced Melanoma
- (2008) Lei Fang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Endpoints for Assessing Drug Activity in Clinical Trials
- (2008) R. Pazdur ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started